BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 24618614)

  • 1. Desmoplastic melanoma with sarcomatoid dedifferentiation.
    Kiuru M; McDermott G; Berger M; Halpern AC; Busam KJ
    Am J Surg Pathol; 2014 Jun; 38(6):864-70. PubMed ID: 24618614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary intrafascial desmoplastic melanoma with pseudoglandular differentiation and aberrant cytokeratins expression: An exceptional presentation.
    Saggini A; Cerroni L; Casini B; Baciorri F; Cota C
    Pathol Res Pract; 2019 Dec; 215(12):152668. PubMed ID: 31585813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD10 and p63 expression in a sarcomatoid undifferentiated melanoma: A cautionary (and molecularly annotated) tale.
    Lefferts JA; Loehrer AP; Yan S; Green DC; Deharvengt SJ; LeBlanc RE
    J Cutan Pathol; 2020 Jun; 47(6):541-547. PubMed ID: 31943331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Undifferentiated Sarcoma as Intermediate Step in the Progression of Malignant Melanoma to Rhabdomyosarcoma: Histologic, Immunohistochemical, and Molecular Studies of a New Case of Malignant Melanoma With Rhabdomyosarcomatous Differentiation.
    Tran TAN; Linos K; de Abreu FB; Carlson JA
    Am J Dermatopathol; 2019 Mar; 41(3):221-229. PubMed ID: 30085960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcoma-like tumor of head and neck skin.
    Nonaka D; Bishop PW
    Am J Surg Pathol; 2014 Jul; 38(7):956-65. PubMed ID: 24705313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of a melanoma in situ to a sarcomatoid dedifferentiated melanoma.
    Chung J; Shevchenko A; Lee JB
    J Cutan Pathol; 2021 Jul; 48(7):943-947. PubMed ID: 33675557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX10 expression distinguishes desmoplastic melanoma from its histologic mimics.
    Palla B; Su A; Binder S; Dry S
    Am J Dermatopathol; 2013 Jul; 35(5):576-81. PubMed ID: 23291581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed versus pure variants of desmoplastic melanoma: a genetic and immunohistochemical appraisal.
    Miller DD; Emley A; Yang S; Richards JE; Lee JE; Deng A; Hoang MP; Mahalingam M
    Mod Pathol; 2012 Apr; 25(4):505-15. PubMed ID: 22157936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous desmoplastic melanoma.
    Busam KJ
    Adv Anat Pathol; 2005 Mar; 12(2):92-102. PubMed ID: 15731577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOX-10 and S100 Negative Desmoplastic Melanoma: Apropos a Diagnostically Challenging Case.
    Kooper-Johnson S; Mahalingam M; Loo DS
    Am J Dermatopathol; 2020 Sep; 42(9):697-699. PubMed ID: 32149837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral Palisading in Melanoma Mimicking Basal Cell Carcinoma: A Case Report.
    Wang Y; Guo Y
    Am J Dermatopathol; 2020 Sep; 42(9):677-679. PubMed ID: 32195676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcomatoid Dedifferentiated Melanoma: The Diagnostic Role of Next-Generation Sequencing.
    Valiga AA; Fuller CG; Doyle JA; Lee JB
    Am J Dermatopathol; 2022 Apr; 44(4):282-286. PubMed ID: 34726188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF1 Mutations Are Common in Desmoplastic Melanoma.
    Wiesner T; Kiuru M; Scott SN; Arcila M; Halpern AC; Hollmann T; Berger MF; Busam KJ
    Am J Surg Pathol; 2015 Oct; 39(10):1357-62. PubMed ID: 26076063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofibromin protein loss in desmoplastic melanoma subtypes: implicating NF1 allelic loss as a distinct genetic driver?
    Kadokura A; Frydenlund N; Leone DA; Yang S; Hoang MP; Deng A; Hernandez-Perez M; Biswas A; Singh R; Yaar R; Mahalingam M
    Hum Pathol; 2016 Jul; 53():82-90. PubMed ID: 26980030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic Malignant Melanoma With Complete Loss of Differentiation Markers (Undifferentiated/Dedifferentiated Melanoma): Analysis of 14 Patients Emphasizing Phenotypic Plasticity and the Value of Molecular Testing as Surrogate Diagnostic Marker.
    Agaimy A; Specht K; Stoehr R; Lorey T; Märkl B; Niedobitek G; Straub M; Hager T; Reis AC; Schilling B; Schneider-Stock R; Hartmann A; Mentzel T
    Am J Surg Pathol; 2016 Feb; 40(2):181-91. PubMed ID: 26448190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic Melanoma With Papillary Features: A Mimic and Possible Diagnostic Pitfall.
    Valero-Torres A; Prieto VG; Nagarajan P; Torres-Cabala CA; Tetzlaff MT; Curry JL; Ivan D; Aung PP
    Am J Dermatopathol; 2017 Jun; 39(6):468-470. PubMed ID: 28525424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
    de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
    Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined Squamomelanocytic Tumor of the Plantar Surface of the Foot: Histogenetic Insights.
    Malhotra KP; Shukla S; Husain N; Bhatt ML
    Am J Dermatopathol; 2016 May; 38(5):396-7. PubMed ID: 26381113
    [No Abstract]   [Full Text] [Related]  

  • 19. An Atypical Fibroxanthoma and Intradermal Nevus Collision Tumor-Potential for Misdiagnosis.
    Steel A; Debbaneh M; Cassarino D
    Am J Dermatopathol; 2019 Aug; 41(8):e87-e89. PubMed ID: 31335430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clear Cell Atypical Fibroxanthoma: Clinicopathological Study of 6 Cases and Review of the Literature With Special Emphasis on the Differential Diagnosis.
    Tardío JC; Pinedo F; Aramburu JA; Martínez-González MÁ; Arias D; Khedaoui R; Suárez-Massa D; Santonja C
    Am J Dermatopathol; 2016 Aug; 38(8):586-92. PubMed ID: 26848640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.